DOCSLIB.ORG

INAUGURAL – DISSERTATION Zur Erlangung Der Doktorwürde Der Naturwissenschaftlich-Mathematischen Gesamtfakultät Der Ruprecht-Karls-Universität Heidelberg

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
INAUGURAL – DISSERTATION Zur Erlangung Der Doktorwürde Der Naturwissenschaftlich-Mathematischen Gesamtfakultät Der Ruprecht-Karls-Universität Heidelberg INAUGURAL – DISSERTATION zur Erlangung der Doktorwürde der Naturwissenschaftlich-Mathematischen Gesamtfakultät der Ruprecht-Karls-Universität Heidelberg vorgelegt von Master of Research Kaiyong Li aus Stuttgart Tag der mündlichen Prüfung: . 2018 Identification of a functional mRNA-miRNA network in mTEC development Gutachter: Prof. Bruno Kyewski / Prof. Nina Papavasiliou Prof. Stefan Wiemann Hiermit erkläre ich, dass ich die vorgelegte Dissertation selbstständig verfasst und mich dabei keiner anderen, als der von mir ausdrücklich bezeichneten Quellen bedient habe. Stuttgart, den 18. Mai 2018 Kaiyong Li This thesis was completed in the Department of Developmental Immunology headed by Prof. Dr. Bruno Kyewski at the German Cancer Research Center Heidelberg Content Content Table of Contents Content ................................................................................................................................. 1 Zusammenfassung ............................................................................................................ 3 Summary .............................................................................................................................. 5 1 Introduction .................................................................................................................... 7 1.1 The evolution and development of the thymus ................................................. 7 1.1.2 The evolution of the adaptive immune system .............................................. 8 1.2.1 The maturation of thymocytes in the thymus ..................................................... 8 1.2.2 The selection of thymocytes and establishment of central tolerance ..... 9 1.2.3 The thymocyte selection model ............................................................................ 11 1.2.4 The discrepancy between cTECs and mTECs ................................................ 11 1.2.5 The maturation of mTECs ........................................................................................ 12 1.2.6 The crosstalk between developing thymocytes and thymus ................... 13 1.3 The Signalling pathways in TEC development ................................................... 14 1.4 microRNAs and their influence in post-translational regulation ................. 15 1.4.1 The involvement of microRNAs in signalling pathways ............................. 18 1.5 microRNAs in thymus development ....................................................................... 19 1.5.1 Functional miRNAs in mTECs ................................................................................ 20 1.1 Objective of this study ............................................................................................ 23 2 Materials and Methods .............................................................................................. 24 2.1 Materials .............................................................................................................................. 24 2.1.1 Chemicals ....................................................................................................................... 24 2.1.2 Dispensable materials and commercial kits .................................................... 26 2.1.3 Media, buffers and commercial solutions ......................................................... 28 2.1.4 Magnetic beads and Microbeads used for MACS purification ................. 30 2.1.5 Antibodies ...................................................................................................................... 31 2.1.6 MiRNA primers, siRNA, antagomiRs and mimics .......................................... 32 2.1.7 Oligonucleotides for vector cloning .................................................................... 35 2.1.8 PCR primers ................................................................................................................... 36 2.1.9 Equipment ...................................................................................................................... 37 2.1.10 Cell lines ....................................................................................................................... 38 2.1.11 Softwares and homepages ................................................................................... 39 2.1.12 Mouse strains ............................................................................................................. 39 2.2 Methods ....................................................................................................................... 41 2.2.1 Isolation of murine tail DNA .................................................................................... 41 2.2.2 Isolation of RNA from sorted cells or tissue .................................................... 41 2.2.3 Isolation of miRNA ...................................................................................................... 42 2.2.4 RNA precipitation ........................................................................................................ 42 2.2.5 MiRNA Reverse Transcription ................................................................................ 42 2.2.6 cDNA Synthesis ........................................................................................................... 42 2.2.7 Genotyping PCR ........................................................................................................... 42 2.2.8 Thymus dissection and medullary epithelial cell preparation ................. 43 1 Content 2.2.9 Thymus dissection and isolation of embryonic medullary thymic epithelial cells .......................................................................................................................... 44 2.2.10 Re-aggregate Thymus Organ Culture (RTOC) .............................................. 45 2.2.11 FACS staining of mTECs ........................................................................................ 46 2.2.12 Bone marrow transplantation .............................................................................. 46 2.2.13 Transient transfections with freshly isolated cells ..................................... 47 2.2.14 Vector generation, Transformation, Co-transfection ................................. 47 2.2.15 Luciferase assay ....................................................................................................... 48 3 Results ............................................................................................................................. 49 3.1 Four subpopulations within the immature mTEC pool ................................... 49 3.2 The four subpopulations in distinct mouse strains .......................................... 50 3.3 The mRNA expression profiling of the four subpopulations ........................ 53 3.4 The miRNA expression profiling of the four subpopulations ....................... 57 3.5 A developmental progression among the four subpopulations ................. 60 3.6 Finding the most prominent miRNAs in the development of immature mTECs ......................................................................................................................................... 62 3.7 Verification of the potential miRNAs in different mouse lines ..................... 63 3.8 A dynamic model to follow the mTEC development ........................................ 68 3.9 A dynamic model to reveal miRNA changes during mTEC development69 3.10 Discovery of dynamic miRNAs during mTEC development ....................... 73 3.11 Investigation of the functional role of our miRNA candidates ................... 75 3.12 Transfection methods on primary cells .............................................................. 76 3.13 Transfection efficacy of mimics and antagomiRs in mTECs ...................... 79 3.14 Further adjustments and optimization of cell numbers and controls .... 82 3.15 A change in the miRNA level has an impact in the four subpopulations ........................................................................................................................................................ 87 3.16 Search of mRNA targets ............................................................................................ 95 3.17 Quick screening of mRNA targets ......................................................................... 96 4 Discussion ................................................................................................................... 101 4.1 Identifying a lineage progression within the four subpopulations ......... 102 4.2 Clusters of miRNA sets in the four subpopulations ...................................... 104 4.3 Usage of different approaches to find potential miRNAs ........................... 106 4.4 Discovery of a new reliable transfection method ........................................... 108 4.5 MicroRNA level changes influence the development of the four subpopulations .................................................................................................................... 109 4.6 Search for relevant mRNA-miRNA pairs ............................................................ 110 4.7 MiRNAs with functional effects .............................................................................. 110 4.8 The new mRNA targets in immature mTECs and their potential involvement in the mTEC development ..................................................................... 111 4.9 Interesting mRNA target for further investigation
Load more

Recommended publications
  • Dog Coat Colour Genetics: a Review Date Published Online: 31/08/2020; 1,2 1 1 3 Rashid Saif *, Ali Iftekhar , Fatima Asif , Mohammad Suliman Alghanem
    www.als-journal.com/ ISSN 2310-5380/ August 2020 Review Article Advancements in Life Sciences – International Quarterly Journal of Biological Sciences ARTICLE INFO Open Access Date Received: 02/05/2020; Date Revised: 20/08/2020; Dog Coat Colour Genetics: A Review Date Published Online: 31/08/2020; 1,2 1 1 3 Rashid Saif *, Ali Iftekhar , Fatima Asif , Mohammad Suliman Alghanem Authors’ Affiliation: 1. Institute of Abstract Biotechnology, Gulab Devi Educational anis lupus familiaris is one of the most beloved pet species with hundreds of world-wide recognized Complex, Lahore - Pakistan breeds, which can be differentiated from each other by specific morphological, behavioral and adoptive 2. Decode Genomics, traits. Morphological characteristics of dog breeds get more attention which can be defined mostly by 323-D, Town II, coat color and its texture, and considered to be incredibly lucrative traits in this valued species. Although Punjab University C Employees Housing the genetic foundation of coat color has been well stated in the literature, but still very little is known about the Scheme, Lahore - growth pattern, hair length and curly coat trait genes. Skin pigmentation is determined by eumelanin and Pakistan 3. Department of pheomelanin switching phenomenon which is under the control of Melanocortin 1 Receptor and Agouti Signaling Biology, Tabuk Protein genes. Genetic variations in the genes involved in pigmentation pathway provide basic understanding of University - Kingdom melanocortin physiology and evolutionary adaptation of this trait. So in this review, we highlighted, gathered and of Saudi Arabia comprehend the genetic mutations, associated and likely to be associated variants in the genes involved in the coat color and texture trait along with their phenotypes.
    [Show full text]
  • Gpnmb in Inflammatory and Metabolic Diseases
    Functional characterization of Gpnmb in inflammatory and metabolic diseases Dissertation zur Erlangung des akademischen Grades D octor rerum naturalium (Dr. rer. nat.) eingereicht an der Lebenswissenschaftlichen Fakultät der Humboldt-Universität zu Berlin von M.Sc., Bernadette Nickl Präsidentin der Humboldt-Universität zu Berlin Prof. Dr.-Ing. Dr. Sabine Kunst Dekan der Lebenswissenschaftlichen Fakultät Prof. Dr. Bernhard Grimm Gutachter: Prof. Dr. Michael Bader Prof. Dr. Karl Stangl Prof. Dr. Thomas Sommer Tag der mündlichen Prüfung: 28. Februar 2020 For Sayeeda Summary Summary In 2018, the World Health Organization reported for the first time that “Overweight and obesity are linked to more deaths worldwide than underweight”A. Obesity increases the risk for the development of diabetes, atherosclerosis and cardiovascular diseases. Those metabolic diseases are associated with inflammation and the expression of glycoprotein nonmetastatic melanoma protein b (Gpnmb), a transmembrane protein that is expressed by macrophages and dendritic cells. We studied the role of Gpnmb in genetically- and diet-induced atherosclerosis as well as diet-induced obesity in Gpnmb-knockout and respective wildtype control mice. To this purpose, a mouse deficient in Gpnmb was created using Crispr-Cas9 technology. Body weight and blood lipid parameters remained unaltered in both diseases. Gpnmb was strongly expressed in atherosclerotic lesion-associated macrophages. Nevertheless, the absence of Gpnmb did not affect the development of aortic lesion size. However, macrophage and inflammation markers in epididymal fat tissue were increased in Gpnmb-deficient mice. In comparison to atherosclerosis, the absence of Gpnmb elicited stronger effects in obesity. For the first time, we observed a positive influence of Gpnmb on insulin and glucose plasma levels.
    [Show full text]
  • BACE1 Inhibitor Drugs in Clinical Trials for Alzheimer's Disease
    Vassar Alzheimer's Research & Therapy (2014) 6:89 DOI 10.1186/s13195-014-0089-7 REVIEW BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease Robert Vassar Abstract β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiology of Alzheimer’s disease (AD). As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued. It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood–brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clinical trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD. Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD. Additionally, based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration. It is hoped that a therapeutic window can be achieved that balances safety and efficacy. This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.
    [Show full text]
  • Amyloid Aggregates Accumulate in Melanoma Metastasis Driving YAP
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.10.941906; this version posted February 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Amyloid aggregates accumulate in melanoma metastasis driving YAP mediated tumor progression Vittoria Matafora1, Francesco Farris1, Umberto Restuccia1, 4, Simone Tamburri1,5, Giuseppe Martano1, Clara Bernardelli1,6, Federica Pisati1,2, Francesca Casagrande1, Luca Lazzari1, Silvia Marsoni1, Emanuela Bonoldi 3 and Angela Bachi1* 1IFOM- FIRC Institute of Molecular Oncology, 20139 Milan, Italy. 2 Cogentech SRL Benefit Corporation, 20139 Milan, Italy. 3 Department of Laboratory Medicine, Division of Pathology, Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy. 4 present address: ADIENNE Pharma & Biotech, 20867 Caponago (MB) – Italy. 5 present address: IEO-European Institute of Oncology IRCCS, Department of Experimental Oncology, 20139 Milan, Italy. 6 present address: Fondazione Politecnico di Milano, 20133 Milan, Italy. * Corresponding author: Angela Bachi IFOM- FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy Phone: +3902574303873 Mail: [email protected] Running Title: Amyloids activate YAP in melanoma Keywords: amyloid; BACE; drug sensitivity; mechanosignalling; metastasis. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.10.941906; this version posted February 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Melanoma progression is generally associated to increased Yes-associated protein (YAP) mediated transcription. Actually, mechanical signals from the extracellular matrix are sensed by YAP, which activates proliferative genes expression, promoting melanoma progression and drug resistance.
    [Show full text]
  • Microarray Analysis of Novel Genes Involved in HSV- 2 Infection
    Microarray analysis of novel genes involved in HSV- 2 infection Hao Zhang Nanjing University of Chinese Medicine Tao Liu ( [email protected] ) Nanjing University of Chinese Medicine https://orcid.org/0000-0002-7654-2995 Research Article Keywords: HSV-2 infection,Microarray analysis,Histospecic gene expression Posted Date: May 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-517057/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background: Herpes simplex virus type 2 infects the body and becomes an incurable and recurring disease. The pathogenesis of HSV-2 infection is not completely clear. Methods: We analyze the GSE18527 dataset in the GEO database in this paper to obtain distinctively displayed genes(DDGs)in the total sequential RNA of the biopsies of normal and lesioned skin groups, healed skin and lesioned skin groups of genital herpes patients, respectively.The related data of 3 cases of normal skin group, 4 cases of lesioned group and 6 cases of healed group were analyzed.The histospecic gene analysis , functional enrichment and protein interaction network analysis of the differential genes were also performed, and the critical components were selected. Results: 40 up-regulated genes and 43 down-regulated genes were isolated by differential performance assay. Histospecic gene analysis of DDGs suggested that the most abundant system for gene expression was the skin, immune system and the nervous system.Through the construction of core gene combinations, protein interaction network analysis and selection of histospecic distribution genes, 17 associated genes were selected CXCL10,MX1,ISG15,IFIT1,IFIT3,IFIT2,OASL,ISG20,RSAD2,GBP1,IFI44L,DDX58,USP18,CXCL11,GBP5,GBP4 and CXCL9.The above genes are mainly located in the skin, immune system, nervous system and reproductive system.
    [Show full text]
  • Identification of the Regions of the Bovine Genome
    IDENTIFICATION OF THE REGIONS OF THE BOVINE GENOME ASSOCIATED WITH GRAY COAT COLOR IN A NELLORE–ANGUS CROSS POPULATION A Thesis by PAUL WESLEY HOLLAND Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements of the degree of MASTER OF SCIENCE Chair of Committee, David G. Riley Committee Members, James O. Sanders Clare A. Gill Andy. D. Herring Head of Department, H. Russell Cross May 2015 Major Subject: Animal Breeding Copyright 2015 Paul Wesley Holland ABSTRACT The genetics of coat color for cattle are important to breeders and breed associations because phenotypes of these animals are used for breed recognition and premiums or discounts can be given due to the phenotypes. The gene for gray coat color has been determined in other species, but not in cattle. Gray in cattle is known to be recessive based upon observed inheritance. The objective of this study was to identify the regions of the bovine genome associated with gray coat color in a population of Nellore-Angus crossbred cattle. Additionally, proportions of each color and spotting were of interest. Animals (n = 1941) were classified into phenotypic color categories (i.e. red, black, gray, etc.). Proportions of each color group out of the population were determined, and the proportion of those phenotypes that have any form of spotting. Two genome-wide association analyses were conducted, one where phenotypically gray vs. not gray cattle were analyzed and another where cattle that were very light in color but had a reddish tinge were included as gray.
    [Show full text]
  • The Complex Relationship Between MITF and the Immune System: a Melanoma Immunotherapy (Response) Factor? Robert Ballotti, Yann Cheli, Corine Bertolotto
    The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? Robert Ballotti, Yann Cheli, Corine Bertolotto To cite this version: Robert Ballotti, Yann Cheli, Corine Bertolotto. The complex relationship between MITF and the im- mune system: a Melanoma ImmunoTherapy (response) Factor?. Molecular Cancer, BioMed Central, 2020, 19 (1), pp.170. 10.1186/s12943-020-01290-7. inserm-03138744 HAL Id: inserm-03138744 https://www.hal.inserm.fr/inserm-03138744 Submitted on 11 Feb 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Ballotti et al. Molecular Cancer (2020) 19:170 https://doi.org/10.1186/s12943-020-01290-7 REVIEW Open Access The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? Robert Ballotti1,2, Yann Cheli1,2 and Corine Bertolotto1,2* Abstract The clinical benefit of immune checkpoint inhibitory therapy (ICT) in advanced melanomas is limited by primary and acquired resistance. The molecular determinants of the resistance have been extensively studied, but these discoveries have not yet been translated into therapeutic benefits. As such, a paradigm shift in melanoma treatment, to surmount the therapeutic impasses linked to the resistance, is an important ongoing challenge.
    [Show full text]
  • Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection
    fgene-11-00358 April 9, 2020 Time: 15:55 # 1 ORIGINAL RESEARCH published: 15 April 2020 doi: 10.3389/fgene.2020.00358 Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection Allen F. Ryan1*, Chanond A. Nasamran2, Kwang Pak1, Clara Draf1, Kathleen M. Fisch2, Nicholas Webster3 and Arwa Kurabi1 1 Departments of Surgery/Otolaryngology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States, 2 Medicine/Center for Computational Biology & Bioinformatics, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States, 3 Medicine/Endocrinology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States Single-cell transcriptomics was used to profile cells of the normal murine middle ear. Clustering analysis of 6770 transcriptomes identified 17 cell clusters corresponding to distinct cell types: five epithelial, three stromal, three lymphocyte, two monocyte, Edited by: two endothelial, one pericyte and one melanocyte cluster. Within some clusters, Amélie Bonnefond, Institut National de la Santé et de la cell subtypes were identified. While many corresponded to those cell types known Recherche Médicale (INSERM), from prior studies, several novel types or subtypes were noted. The results indicate France unexpected cellular diversity within the resting middle ear mucosa. The resolution of Reviewed by: Fabien Delahaye, uncomplicated, acute, otitis media is too rapid for cognate immunity to play a major Institut Pasteur de Lille, France role. Thus innate immunity is likely responsible for normal recovery from middle ear Nelson L. S. Tang, infection. The need for rapid response to pathogens suggests that innate immune The Chinese University of Hong Kong, China genes may be constitutively expressed by middle ear cells.
    [Show full text]
  • MITF Expression Predicts Therapeutic Vulnerability to P300 Inhibition in Human Melanoma Edward Kim1, Beth E
    Published OnlineFirst March 25, 2019; DOI: 10.1158/0008-5472.CAN-18-2331 Cancer Tumor Biology and Immunology Research MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma Edward Kim1, Beth E. Zucconi2,3, Muzhou Wu1, Sarah E. Nocco1, David J. Meyers4, Jean S. McGee1, Samantha Venkatesh1, Daniel L. Cohen1, Estela C. Gonzalez1, Byungwoo Ryu1, Philip A. Cole2,3, and Rhoda M. Alani1 Abstract Histone modifications, largely regulated by histone acetyl- p300–MITF axis driving cell growth that is selectively activated transferases (HAT) and histone deacetylases, have been rec- in human melanomas. Targeted chemical inhibition of p300 ognized as major regulatory mechanisms governing human acetyltransferase activity using a potent and selective catalytic diseases, including cancer. Despite significant effort and recent p300/CBP inhibitor demonstrated significant growth inhibi- advances, the mechanism by which the HAT and transcrip- tory effects in melanoma cells expressing high levels of tional coactivator p300 mediates tumorigenesis remains MITF. Collectively, these data confirm the critical role of the unclear. Here, we use a genetic and chemical approach to p300–MITF–FOXM1 axis in melanoma and support p300 as a identify the microphthalmia-associated transcription factor promising novel epigenetic therapeutic target in human (MITF) as a critical downstream target of p300 driving human melanoma. melanoma growth. Direct transcriptional control of MITF by p300-dependent histone acetylation within proximal gene Significance: These results show that MITF is a major regulatory regions was coupled to cellular proliferation, sug- downstream target of p300 in human melanoma whose gesting a significant growth regulatory axis. Further analysis expression is predictive of melanoma response to small- revealed forkhead box M1 (FOXM1) as a key effector of the molecule inhibition of p300 HAT activity.
    [Show full text]
  • A Melanocyte-Specific Gene, Pmel 17, Maps Near the Silver Coat Color Locus on Mouse Chromosome 10 and Is in a Syntenic Region On
    Proc. Natl. Acad. Sci. USA Vol. 88, pp. 9228-9232, October 1991 Genetics A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12 (pigmentation/silver locus) BYOUNG S. KWON*t, CHAYA CHINTAMANENI*, CHRISTINE A. KOZAKt, NEAL G. COPELAND§, DEBRA J. GILBERT§, NANCY JENKINS§, DAVID BARTON II, UTA FRANCKE¶**, YVONNE KOBAYASHI*, AND KACK K. KIM* *Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202; tLaboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; §Mammalian Genetics Laboratory, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702; and IDepartment of Human Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510 Communicated by Elizabeth S. Russell, July 8, 1991 ABSTRACT Melanocytes preferentially express an mRNA was referred to as Pmel 17-1.tt We demonstrated that the species, Pmel 17, whose protein product cross-reacts with gene for Pmel 17-1 did not map to the c locus on mouse anti-tyrosinase antibodies and whose expression correlates with chromosome 7 (10) and that the transcript of Pmel 17-1 was the melanin content. We have now analyzed the deduced preferentially detected in melanocytes but not in nonpig- protein structure and mapped its chromosomal location in mented cells. mouse and human. The amino acid sequence deduced from the Mouse molecular genetic linkage maps have proved in- nucleotide sequence of the Pmel 17 cDNA showed that the valuable for the structural and functional characterization of protein is composed of645 amino acids with a molecular weight the mouse genome.
    [Show full text]
  • Glycoprotein Nonmetastatic Melanoma Protein B: a Key Mediator and an Emerging Therapeutic Target in Autoimmune Diseases
    Glycoprotein nonmetastatic melanoma protein B: a key mediator and an emerging therapeutic target in autoimmune diseases Pei-Suen Tsou1 and Amr H. Sawalha2,3,4 1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA 2Division of Rheumatology, Department of Pediatrics, University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA 3Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 4Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Address correspondence: Amr H. Sawalha, Division of Pediatric Rheumatology, University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, 4401 Penn Avenue, Pittsburgh, PA 15224, USA. Telephone (412) 692- 8140. Fax (412) 692-5054. Email: [email protected] Abbreviations GPMNB: Glycoprotein nonmetastatic melanoma protein B Author Manuscript Author OA: Osteoactivin This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/FSB2.20630 This article is protected by copyright. All rights reserved DC-HIL: Dendritic cell-heparin integrin ligand SIG: N-terminal signal peptide NTD: N-terminal domain (NTD) PKD: Polycystic kidney disease
    [Show full text]
  • Rossi, Nicole.Pdf
    REGULATION OF LENS PHENOTYPE VIA TRANSLATIONAL REPRESSION OF RETINAL MARKERS BY LACTASE LIKE & AN INVESTIGATION OF POSTERIOR CAPSULAR OPACIFICATION by Nicole M. Rossi A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the Honors Bachelor of Science in Biological Sciences with Distinction Spring 2020 © 2020 Nicole M. Rossi All Rights Reserved REGULATION OF LENS PHENOTYPE VIA TRANSLATIONAL REPRESSION OF RETINAL MARKERS BY LACTASE LIKE by Nicole M. Rossi Approved: __________________________________________________________ Dr. Melinda K. Duncan, Ph.D. Professor in charge of thesis on behalf of the Advisory Committee Approved: __________________________________________________________ Dr. Shuo Wei, Ph.D. Committee member from the Department of Biological Sciences Approved: __________________________________________________________ Dr. Gary Laverty, Ph.D. Committee member from the Board of Senior Thesis Readers Approved: __________________________________________________________ Dr. Michael Chajes, Ph.D. Faculty Director, University Honors Program ACKNOWLEDGMENTS I would like to thank Dr. Melinda K. Duncan, Mahbubul H. Shihan, and the other members of my lab for providing me resources and support during the writing of this paper. Thank you to the University of Delaware Biological Sciences Department for providing me the opportunity to perform this research. Lastly, I would like to thank my parents, for always believing in me. iii TABLE OF CONTENTS LIST OF TABLES ........................................................................................................
    [Show full text]